HHealthcare Read More The Best Healthcare Stocks to Buy With $50 Right NowMarch 18, 2026 It’s not hard to find healthcare stocks, including small-cap biotech companies, trading below $50 per share. However, many…
HHealthcare Read More 3 Healthcare Stocks Paying the Highest Dividends of 2026March 10, 2026 Could your portfolio use some more exposure to the healthcare sector as well as more income? If so,…
HHealthcare Read More 2 Top AI Healthcare Stocks to Buy and HoldMarch 10, 2026 Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However,…
MMedication Read More List of medications seeing major price changes in 2026March 6, 2026 A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of…
HHealthcare Read More This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious IncomeFebruary 25, 2026 Pfizer (NYSE: PFE) is one of the world’s largest and most respected pharmaceutical companies. That is an important…
HHealthcare Read More Is Pfizer Stock an Underrated Healthcare Investment Play?February 21, 2026 Pharmaceutical giant Pfizer (NYSE: PFE) recently had to drop its internally developed GLP-1 weight loss drug candidate. The…
HHealthcare Read More Pfizer Bets On Monthly GLP-1 Obesity Drug To Reshape Growth StoryFebruary 6, 2026 Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
HHealthcare Read More Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026February 4, 2026 Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…
HHealthcare Read More Japan’s Shionogi boosts ViiV stake in $2.13 billion deal as Pfizer exitsJanuary 22, 2026 Jan 20 (Reuters) – Japan’s Shionogi & Co said on Tuesday it ​would pay $2.13 billion for new…
BBusiness Read More Bayer’s Monsanto sues Pfizer, BioNTech and Moderna over mRNA technologyJanuary 7, 2026 Bayer’s Monsanto has sued COVID vaccine makers Pfizer, BioNTech and Moderna, for allegedly misusing its messenger RNA (mRNA)…
MMedication Read More Should You Buy Pfizer While It’s Under $30?January 1, 2026 Pfizer has been struggling for several years. The company’s pipeline could help it turn things around. It also…
HHealthcare Read More Better Buy in 2026: Pfizer or Eli Lilly?December 18, 2025 Eli Lilly has been a dominant force in the GLP-1 market, and that looks set to continue. Pfizer’s…